Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 04.06.18 in Vol 7, No 6 (2018): June

This paper is in the following e-collection/theme issue:

Works citing "Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.9043):

(note that this is only a small subset of citations)

  1. Nic An Riogh E, Swan D, McCombe G, O’Connor E, Avramovic G, Macías J, Oprea C, Story A, Surey J, Vickerman P, Ward Z, Lambert JS, Tinago W, Ianache I, Iglesias M, Cullen W. Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community care. Journal of Antimicrobial Chemotherapy 2019;74(Supplement_5):v31
    CrossRef
  2. Pozza R, McCoy-Hill C, Hall K, Hefner A, Wilgers K, Tapelband J, Masroor M, Hassanein T. Eradicating hepatitis C virus. The Nurse Practitioner 2019;44(11):16
    CrossRef
  3. Murtagh R, Swan D, O'Connor E, McCombe G, Lambert JS, Avramovic G, Cullen W. Hepatitis C Prevalence and Management Among Patients Receiving Opioid Substitution Treatment in General Practice in Ireland: Baseline Data from a Feasibility Study. Interactive Journal of Medical Research 2018;7(2):e10313
    CrossRef